Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Moligand™, ≥97% Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 3 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Information
Liproxstatin-1 Liproxstatin-1 is a potent ferroptosis inhibitor with an IC50 of 22 nM.
Targets
ferroptosis (Cell-free assay) 22 nM
In vitro
Liproxstatin-1 is able to inhibit ferroptosis in the low nanomolar range and inhibit the growth of Gpx4−/−cells with IC50 of 22 nM. Liproxstatin-1 (50 nM) completely prevents lipid peroxidation in Gpx4−/−cells. Liproxstatin-1 (200 nM) protects against FINs, such as BSO (10 µM), erastin (1 µM) and RSL3 (0.5 µM), in a dose dependent manner, whereas it fails to rescue cell death induced by staurosporine (0.2 µM) and H2O2 (200 µM).
In vivo
Liproxstatin-1 remarkably extends survival compared with the vehicle-treated group, delays ferroptosis in tubular cells, and mitigates tissue injury in ischaemia/reperfusion-induced liver injury.
Cell Research(from reference)
Cell lines:Gpx4−/−cells
Concentrations:~200 nM
Incubation Time:~72 h
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organoheterocyclic compounds |
| Class | Diazanaphthalenes |
| Subclass | Benzodiazines |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Quinoxalines |
| Alternative Parents | Benzylamines Secondary alkylarylamines Chlorobenzenes Piperidines Imidolactams Aryl chlorides Propargyl-type 1,3-dipolar organic compounds Dialkylamines Carboxamidines Azacyclic compounds Organochlorides Hydrocarbon derivatives |
| Molecular Framework | Aromatic heteropolycyclic compounds |
| Substituents | Quinoxaline - Benzylamine - Chlorobenzene - Halobenzene - Secondary aliphatic/aromatic amine - Aryl chloride - Aryl halide - Monocyclic benzene moiety - Piperidine - Imidolactam - Benzenoid - Azacycle - Secondary aliphatic amine - Carboxylic acid amidine - Amidine - Organic 1,3-dipolar compound - Secondary amine - Propargyl-type 1,3-dipolar organic compound - Organonitrogen compound - Organochloride - Organohalogen compound - Hydrocarbon derivative - Organic nitrogen compound - Amine - Aromatic heteropolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as quinoxalines. These are compounds containing a quinoxaline moiety, a bicyclic heterocycle made up of a benzene ring fused to a pyrazine ring. |
| External Descriptors | Not available |
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | May 20, 2026 | L413818 | |
| Certificate of Analysis | May 20, 2026 | L413818 | |
| Certificate of Analysis | May 20, 2026 | L413818 | |
| Certificate of Analysis | May 20, 2026 | L413818 | |
| Certificate of Analysis | May 20, 2026 | L413818 | |
| Certificate of Analysis | May 20, 2026 | L413818 | |
| Certificate of Analysis | May 20, 2026 | L413818 | |
| Certificate of Analysis | Sep 10, 2025 | L413818 | |
| Certificate of Analysis | Sep 10, 2025 | L413818 | |
| Certificate of Analysis | Sep 10, 2025 | L413818 | |
| Certificate of Analysis | Sep 10, 2025 | L413818 | |
| Certificate of Analysis | Sep 10, 2025 | L413818 | |
| Certificate of Analysis | Sep 10, 2025 | L413818 | |
| Certificate of Analysis | May 27, 2025 | L413818 | |
| Certificate of Analysis | May 27, 2025 | L413818 | |
| Certificate of Analysis | May 27, 2025 | L413818 | |
| Certificate of Analysis | May 12, 2025 | L413818 | |
| Certificate of Analysis | May 12, 2025 | L413818 | |
| Certificate of Analysis | Jul 20, 2023 | L413818 | |
| Certificate of Analysis | Jul 20, 2023 | L413818 | |
| Certificate of Analysis | Jul 20, 2023 | L413818 | |
| Certificate of Analysis | Jul 20, 2023 | L413818 | |
| Certificate of Analysis | Jul 20, 2023 | L413818 | |
| Certificate of Analysis | Jun 13, 2022 | L413818 |
| Solubility | Solubility (25°C) In vitro Ethanol: 4 mg/mL warmed with 50ºC Water: bath (11.73 mM); DMSO: Insoluble; Water: Insoluble; |
|---|---|
| DMSO(mg / mL) Max Solubility | 68 |
| DMSO(mM) Max Solubility | 199.5012469 |
| Water(mg / mL) Max Solubility | <1 |
| Molecular Weight | 340.800 g/mol |
| XLogP3 | 3.200 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 340.145 Da |
| Monoisotopic Mass | 340.145 Da |
| Topological Polar Surface Area | 48.500 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 460.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
View Moligand™ grade guide →